Evaluation of a novel disposable esophagogastroduodenoscopy system in emergency, bedside, and intraoperative settings: Pilot study (with videos).
Ze-Long Han, Bi-Tao Lin, Zhen-Jiang Wang...
https://pubmed.ncbi.nlm.nih.gov/36905288/Actively Recruiting
Led by Zealand University Hospital · Updated on 2026-01-09
700
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating whether single-use gastroscopes perform as well as reusable gastroscopes during gastroscopy procedures conducted in the operating theater. The study aims to determine if the technical success and performance characteristics of single-use devices match those of reusable ones across patients who need gastroscopy in this setting. Participants will first undergo gastroscopy using single-use gastroscopes, specifically the CE-marked Ambu aScope Gastro and Ambu aScope Gastro Large devices. In a subsequent period, gastroscopies will be performed using reusable gastroscopes from Olympus, including both diagnostic and therapeutic models. This comparison spans acute, subacute, and elective patients undergoing procedures in the operating room. Throughout the study, researchers will assess technical success from admission until discharge, with follow-up up to three months. They will also monitor complications at 24 and 72 hours post-procedure, mortality at 30 days, procedure duration, endoscopist satisfaction, and the need for additional gastroscopies or readmission. Biopsy targeting success and time from procedure to discharge will also be evaluated to understand the overall performance and outcomes associated with each gastroscope type.
CONDITIONS
Performance Characteristics and Technical Outcomes of Single-use vs. Reusable Gastroscopes Evaluated in the OR
C
Camilla Kjelkvist-Born, MD
M
Marie Louise Malmstrøm, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Zealand University Hospital
Lead Sponsor
University Hospital, Umeå
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From procedure until discharge, up to 3 months
Participants undergo gastroscopy using either single-use or reusable gastroscopes in the operating room.
1 procedure visit and up to 3 months follow-up
Duration - Up to 3 months after procedure
Participants are monitored for complications and recovery after the gastroscopy procedure.
Visits at 24 hours, 72 hours, and 30 days after procedure
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ze-Long Han, Bi-Tao Lin, Zhen-Jiang Wang...
https://pubmed.ncbi.nlm.nih.gov/36905288/Nauzer Forbes, B Joseph Elmunzer, Thibault Allain...
https://pubmed.ncbi.nlm.nih.gov/36689215/Anna Mackiewicz-Pracka, Piotr Nehring, Adam Przybyłkowski
https://pubmed.ncbi.nlm.nih.gov/38066825/Sathvik Namburar, Daniel von Renteln, John Damianos...
https://pubmed.ncbi.nlm.nih.gov/34853058/Vincenzo Cennamo, Alberto Botter, Stefano Landi...
https://pubmed.ncbi.nlm.nih.gov/38504744/Koen van der Ploeg, Pieter J F de Jonge, Wim J Lammers...
https://pubmed.ncbi.nlm.nih.gov/38504741/Sara Larsen, Anthony Kalloo, Susan Hutfless
https://pubmed.ncbi.nlm.nih.gov/31413166/Marco J Bruno, Torsten Beyna, David Carr-Locke...
https://pubmed.ncbi.nlm.nih.gov/37463599/Xiaoya Luo, Ming Ji, Shutian Zhang...
https://pubmed.ncbi.nlm.nih.gov/35381230/Enrique Rodríguez de Santiago, Mario Dinis-Ribeiro, Heiko Pohl...
https://pubmed.ncbi.nlm.nih.gov/35803275/Zealand University Hospital
Lead Sponsor
University Hospital, Umeå
Collaborating Sponsor